Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Zimberelimab's trials
VELOCITY-Lung
Study of Novel Treatment Combinations in Patients With Lung Cancer
Zimberelimab (ZIM)
Ongoing
Active not recruiting
Phase 2
Open NCT05633667 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record